「and a」の検索結果
107件：26～30件目を表示
-
学会发表 | 研究与开发 | 千寿制药株式会社
催日：2024年11月9日 開催地：コングレスクエア羽田 A Novel TRPV1 Antagonist, SJP-0132 for Dry Eye Disease – Results of a Randomized, Double-Masked, Placebo-Controlled Phase 1/2 Study Tomoyuki Wada, PhD 1; Stephen C Pflugfe...
http://www.senju.co.jp/chinese/rd/society/ -
学会発表実績 | 研究開発活動 | 千寿製薬株式会社
催日：2024年11月9日 開催地：コングレスクエア羽田 A Novel TRPV1 Antagonist, SJP-0132 for Dry Eye Disease – Results of a Randomized, Double-Masked, Placebo-Controlled Phase 1/2 Study Tomoyuki Wada, PhD 1; Stephen C Pflugfe...
https://www.senju.co.jp/rd/society/ -
General Announcement: April 23, 2024 Senju Pharmaceutical Co., Ltd. Launch and Distribution of “MIEr for NAVIS” Senju Pharmaceutical Co., Ltd., hereby announces the commercial launch and distribution ...
https://www.senju.co.jp/sites/default/files/content_news/2024-04/ENG_20240423_0.pdf -
General Announcement: Nov 26, 2024 Senju Pharmaceutical Co., Ltd. Launch and Distribution of “MIEr for ImageFS” Senju Pharmaceutical Co., Ltd., hereby announces the commercial launch and distribution ...
https://www.senju.co.jp/sites/default/files/content_news/2024-11/ENG_20241126_0.pdf -
0008, occurs when central retinal artery occlusion leads to irreversible impairment of visual field and vision loss. Approximately 90% of patients suffer severe visual impairment, resulting in less th...
https://www.senju.co.jp/sites/default/files/content_news/2024-05/ENG_20240509.pdf